BETALIN S Drug Patent Profile
✉ Email this page to a colleague
When do Betalin S patents expire, and what generic alternatives are available?
Betalin S is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in BETALIN S is thiamine hydrochloride. There is one drug master file entry for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the thiamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Betalin S
A generic version of BETALIN S was approved as thiamine hydrochloride by WEST-WARD PHARMS INT on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BETALIN S?
- What are the global sales for BETALIN S?
- What is Average Wholesale Price for BETALIN S?
Summary for BETALIN S
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 133 |
| Patent Applications: | 4,431 |
| DailyMed Link: | BETALIN S at DailyMed |
US Patents and Regulatory Information for BETALIN S
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | BETALIN S | thiamine hydrochloride | INJECTABLE;INJECTION | 080853-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
